BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 929742)

  • 1. [Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy].
    Mouridsen HT; Palshof T; Brahm M; Rahbek I
    Ugeskr Laeger; 1977 Oct; 139(44):2632-5. PubMed ID: 929742
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT; Palshof T
    Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination chemotherapy for disseminated carcinoma of the breast.
    Lozada JA; Grillo-López A; Vélez-Garciá E
    Bol Asoc Med P R; 1975 Jun; 67(6):157-63. PubMed ID: 1055588
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast.
    Smalley RV; Murphy S; Huguley CM; Bartolucci AA
    Cancer Res; 1976 Nov; 36(11 Pt 1):3911-6. PubMed ID: 975039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Control studies on the cytostatic combination therapy in metastasizing breast carcinoma].
    Brunner KW; Martz G; Senn HJ; Obrecht P; Alberto P; Melchert F
    Internist (Berl); 1973 Dec; 14(12):643-52. PubMed ID: 4593011
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination chemotherapy in advanced breast cancer.: a randomized trial comparing a three-vs a five-drug program.
    Muss HB; White DR; Cooper MR; Richards F; Spurr CL
    Arch Intern Med; 1977 Dec; 137(12):1711-4. PubMed ID: 337916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytostatic combination therapy in metastatic breast cancer].
    Mouridsen HT
    Ugeskr Laeger; 1973 Jun; 135(25):1336-40. PubMed ID: 4757127
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combination cytostatic chemotherapy of advanced metastatic cancer of the prostate. A preliminary uncontrolled study].
    Ogaard S; Jensen TS
    Ugeskr Laeger; 1977 Feb; 139(9):515-7. PubMed ID: 841743
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of single-drug versus multiple-drug chemotherapy in the treatment of advanced breast cancer.
    Mouridsen HT; Palshof T; Brahm M; Rahbek I
    Cancer Treat Rep; 1977; 61(1):47-50. PubMed ID: 324620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormone therapy and chemotherapy of metastasizing breast cancer. Experiences of the Basle Oncology Center, 1969-72].
    Byland W; Nagel G; Senn HJ
    Schweiz Med Wochenschr; 1974 Aug; 104(31):1077-85. PubMed ID: 4445838
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy for breast cancer.
    Allegra JC; Lippman ME
    Compr Ther; 1979 Feb; 5(2):13-7. PubMed ID: 428200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The polychemotherapeutic treatment of advanced breast cancer.
    Brown I; Arthur K; Banks AJ; Bond WH; Chowdhury MS; Freeman WE; Holme GM; Jones WG; Newsholme GA; Ward HW
    Clin Oncol; 1977 Jun; 3(2):183-9. PubMed ID: 872472
    [No Abstract]   [Full Text] [Related]  

  • 14. Doxorubicin in the treatment of advanced breast cancer; comparative studies of three combination chemotherapy regimes.
    Brown I; Ward HW
    Clin Oncol; 1976 Jun; 2(2):105-11. PubMed ID: 954258
    [No Abstract]   [Full Text] [Related]  

  • 15. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy of common solid tumours in a general surgical unit.
    Jones KD; Hughes LE
    Clin Oncol; 1979 Mar; 5(1):51-63. PubMed ID: 421387
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cytostatic therapy in metastasizing breast cancer].
    Gynning I; Mattsson W
    Lakartidningen; 1978 Apr; 75(15):1512-5. PubMed ID: 651418
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experiences with drug therapy of advanced metastatic carcinoma of the breast (author's transl)].
    Nüvemann M; Fernholz HJ; Frik W
    Med Klin; 1976 Oct; 71(40):1676-83. PubMed ID: 184372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Iatrogenic diabetic coma. Contribution to adverse effects of cytostatic therapy].
    Barb U; Vielberg H
    Strahlentherapie; 1973 Feb; 145(2):234-7. PubMed ID: 4694661
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chemotherapy of inoperable breast cancer with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisolone].
    Raevskiĭ IG
    Sov Med; 1976 Aug; (8):112-4. PubMed ID: 1006408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.